1. Home
  2. BNKK vs CNSP Comparison

BNKK vs CNSP Comparison

Compare BNKK & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNKK

Bonk Inc.

HOLD

Current Price

$1.31

Market Cap

10.6M

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$5.80

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNKK
CNSP
Founded
2018
2017
Country
United States
United States
Employees
10
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
8.5M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
BNKK
CNSP
Price
$1.31
$5.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
110.6K
6.8K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.03
EPS
N/A
N/A
Revenue
$2,117,309.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
201.63
N/A
52 Week Low
$0.11
$1.90
52 Week High
$7.19
$10.59

Technical Indicators

Market Signals
Indicator
BNKK
CNSP
Relative Strength Index (RSI) 62.31 54.30
Support Level $1.25 $4.63
Resistance Level $1.66 $6.19
Average True Range (ATR) 0.11 0.41
MACD 0.05 -0.01
Stochastic Oscillator 77.04 64.93

Price Performance

Historical Comparison
BNKK
CNSP

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Share on Social Networks: